Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose-Reference-Cited by-同舟云学术

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

Published:2022-02 Issue:10325 Volume:399 Page:625-626
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kuhlmann Constanze,Mayer Carla Konstanze,Claassen Mathilda,Maponga Tongai,Burgers Wendy A,Keeton Roanne,Riou Catherine,Sutherland Andrew D,Suliman Tasnim,Shaw Megan L,Preiser Wolfgang

Funder

Poliomyelitis Research Foundation

South African Medical Research Council

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Increased risk of SARS-CoV-2 reinfection associated with emergence of the omicron variant in South Africa;Pulliam;medRxiv,2021

2. Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination;Grupel;Vaccine,2021

3. Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults;Demonbreun;medRxiv,2021

4. Virological assessment of hospitalized patients with COVID-2019;Wölfel;Nature,2020

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters;Science Advances;2024-08-02

3. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination;Infectious Diseases Now;2024-08

4. Lower levels of household transmission of SARS-CoV-2 VOC Omicron compared to Wild-type: an interplay between transmissibility and immune status;2024-07-16

5. Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection;Vaccine;2024-07